Galli, E. (2022) “[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]”, Farmeconomia. Health economics and therapeutic pathways, 23(1). doi: 10.7175/fe.v23i1.1527.